melatonin has been researched along with Glial Cell Tumors in 25 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Melatonin, an indolamine mostly synthesized in the pineal gland, exerts the anti-cancer effect by various mechanisms in glioma cells." | 7.85 | Melatonin inhibits proliferation and invasion via repression of miRNA-155 in glioma cells. ( Chen, Y; Gu, J; Ji, C; Lei, Z; Li, X; Liu, Y; Lu, Z; Wang, L; Zhang, HT, 2017) |
| "Melatonin, a well-known antioxidant, has been shown to possess anti-invasive properties for glioma." | 7.81 | Involvement of ROS-alpha v beta 3 integrin-FAK/Pyk2 in the inhibitory effect of melatonin on U251 glioma cell migration and invasion under hypoxia. ( Cao, CJ; Dai, LM; Huang, XD; Li, ZQ; Wang, ZF; Xu, CS, 2015) |
| "Pretreatment with melatonin effectively promoted Nrf2 activation and reversed the METH-induced NF-κB response." | 5.42 | Melatonin Protects Methamphetamine-Induced Neuroinflammation Through NF-κB and Nrf2 Pathways in Glioma Cell Line. ( Govitrapong, P; Jumnongprakhon, P; Pinkaew, D; Tocharus, C; Tocharus, J, 2015) |
| "Melatonin is an indolamine mostly produced in the pineal gland, soluble in water, and highly lipophilic, which allows it to readily cross the blood-brain barrier." | 5.33 | Intracellular signaling pathways involved in the cell growth inhibition of glioma cells by melatonin. ( Antolín, I; Carrera-Gonzalez, P; García-Santos, G; Herrera, F; Martín, V; Rodriguez, C; Rodriguez-Blanco, J, 2006) |
| "Melatonin, an indolamine mostly synthesized in the pineal gland, exerts the anti-cancer effect by various mechanisms in glioma cells." | 3.85 | Melatonin inhibits proliferation and invasion via repression of miRNA-155 in glioma cells. ( Chen, Y; Gu, J; Ji, C; Lei, Z; Li, X; Liu, Y; Lu, Z; Wang, L; Zhang, HT, 2017) |
| "Melatonin, a well-known antioxidant, has been shown to possess anti-invasive properties for glioma." | 3.81 | Involvement of ROS-alpha v beta 3 integrin-FAK/Pyk2 in the inhibitory effect of melatonin on U251 glioma cell migration and invasion under hypoxia. ( Cao, CJ; Dai, LM; Huang, XD; Li, ZQ; Wang, ZF; Xu, CS, 2015) |
| "Confirmed lesions included pineocytoma WHO grade I (60." | 3.01 | Primary Gamma Knife Radiosurgery for pineal region tumors: A systematic review and pooled analysis of available literature with histological stratification. ( De Domenico, P; Gagliardi, F; Garbin, E; Mortini, P; Snider, S, 2023) |
| "Gliomas, the most common primary brain tumors in adults, are classified into four malignancy grades according to morphological features." | 1.43 | Melatonergic system-based two-gene index is prognostic in human gliomas. ( Carvalho-Sousa, CE; Fernandes, PA; Kinker, GS; Marie, SK; Markus, RP; Muxel, SM; Oba-Shinjo, SM, 2016) |
| "Pretreatment with melatonin effectively promoted Nrf2 activation and reversed the METH-induced NF-κB response." | 1.42 | Melatonin Protects Methamphetamine-Induced Neuroinflammation Through NF-κB and Nrf2 Pathways in Glioma Cell Line. ( Govitrapong, P; Jumnongprakhon, P; Pinkaew, D; Tocharus, C; Tocharus, J, 2015) |
| "Melatonin not only plays an important role in regulating circadian rhythms, but is also involved in antioxidative defense and immunomodulation." | 1.39 | Serotoninergic and melatoninergic systems are expressed in mouse embryonic fibroblasts NIH3T3 cells. ( Liu, YJ; Meng, FT; Wu, L; Zhou, JN, 2013) |
| "Melatonin is an indolamine mostly produced in the pineal gland, soluble in water, and highly lipophilic, which allows it to readily cross the blood-brain barrier." | 1.33 | Intracellular signaling pathways involved in the cell growth inhibition of glioma cells by melatonin. ( Antolín, I; Carrera-Gonzalez, P; García-Santos, G; Herrera, F; Martín, V; Rodriguez, C; Rodriguez-Blanco, J, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (20.00) | 29.6817 |
| 2010's | 14 (56.00) | 24.3611 |
| 2020's | 5 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, W | 3 |
| Song, G | 3 |
| Gagliardi, F | 1 |
| De Domenico, P | 1 |
| Garbin, E | 1 |
| Snider, S | 1 |
| Mortini, P | 1 |
| Anderson, G | 2 |
| Hartung, EE | 1 |
| Mukhtar, SZ | 1 |
| Shah, SM | 1 |
| Niles, LP | 2 |
| Wang, C | 1 |
| Zhao, Z | 1 |
| Qi, Q | 1 |
| Wang, J | 3 |
| Kong, Y | 1 |
| Feng, Z | 1 |
| Chen, A | 1 |
| Li, W | 1 |
| Zhang, Q | 1 |
| Huang, B | 1 |
| Li, X | 2 |
| Gu, J | 1 |
| Lu, Z | 1 |
| Ji, C | 1 |
| Chen, Y | 1 |
| Liu, Y | 1 |
| Lei, Z | 1 |
| Wang, L | 1 |
| Zhang, HT | 1 |
| Ma, H | 1 |
| Wang, Z | 1 |
| Hu, L | 1 |
| Zhang, S | 1 |
| Zhao, C | 1 |
| Yang, H | 1 |
| Wang, H | 1 |
| Fang, Z | 1 |
| Wu, L | 2 |
| Chen, X | 1 |
| Franco, DG | 1 |
| Moretti, IF | 1 |
| Marie, SKN | 1 |
| Maitra, S | 1 |
| Bhattacharya, D | 1 |
| Das, S | 1 |
| Bhattacharya, S | 1 |
| Liu, YJ | 1 |
| Meng, FT | 1 |
| Zhou, JN | 1 |
| Martín, V | 4 |
| Sanchez-Sanchez, AM | 1 |
| Puente-Moncada, N | 1 |
| Gomez-Lobo, M | 1 |
| Alvarez-Vega, MA | 1 |
| Antolín, I | 4 |
| Rodriguez, C | 4 |
| Xu, CS | 1 |
| Wang, ZF | 1 |
| Huang, XD | 1 |
| Dai, LM | 1 |
| Cao, CJ | 1 |
| Li, ZQ | 1 |
| Jumnongprakhon, P | 2 |
| Govitrapong, P | 2 |
| Tocharus, C | 2 |
| Pinkaew, D | 1 |
| Tocharus, J | 2 |
| Kinker, GS | 1 |
| Oba-Shinjo, SM | 1 |
| Carvalho-Sousa, CE | 1 |
| Muxel, SM | 1 |
| Marie, SK | 1 |
| Markus, RP | 1 |
| Fernandes, PA | 1 |
| Beischlag, TV | 1 |
| Mazzoccoli, G | 1 |
| Tungkum, W | 1 |
| García-Santos, G | 3 |
| Rodriguez-Blanco, J | 3 |
| Casado-Zapico, S | 1 |
| Sanchez-Sanchez, A | 1 |
| Medina, M | 2 |
| González, A | 2 |
| Martínez-Campa, C | 2 |
| Mediavilla, MD | 2 |
| Alonso-González, C | 2 |
| Alvarez-García, V | 1 |
| Sánchez-Barceló, EJ | 2 |
| Cos, S | 2 |
| Hao, H | 1 |
| Yao, L | 1 |
| Zhang, X | 1 |
| Zhao, S | 1 |
| Ling, EA | 1 |
| Hao, A | 1 |
| Li, G | 1 |
| Herrera, F | 2 |
| Carrera-Gonzalez, P | 1 |
| Wion, D | 1 |
| Berger, F | 1 |
| Wion-Barbot, N | 1 |
| Arenander, AT | 1 |
| de Vellis, J | 1 |
| Armstrong, KJ | 1 |
3 reviews available for melatonin and Glial Cell Tumors
| Article | Year |
|---|---|
Primary Gamma Knife Radiosurgery for pineal region tumors: A systematic review and pooled analysis of available literature with histological stratification.
Topics: Brain Neoplasms; Glioma; Humans; Melatonin; Neoplasms, Germ Cell and Embryonal; Pineal Gland; Pineal | 2023 |
Melatonin and its anti-glioma functions: a comprehensive review.
Topics: Animals; Antineoplastic Agents; Antioxidants; Brain Neoplasms; Glioma; Humans; Melatonin; Signal Tra | 2019 |
Glioma: Tryptophan Catabolite and Melatoninergic Pathways Link microRNA, 14-3- 3, Chromosome 4q35, Epigenetic Processes and other Glioma Biochemical Changes.
Topics: Animals; Chromosomes, Human, Pair 4; Epigenesis, Genetic; Glioma; Humans; Inflammation; Melatonin; M | 2016 |
22 other studies available for melatonin and Glial Cell Tumors
| Article | Year |
|---|---|
A comprehensive analysis-based study of triphenyl phosphate-environmental explanation of glioma progression.
Topics: Flame Retardants; Glioma; Humans; Liver Neoplasms; Male; Melatonin | 2022 |
A comprehensive analysis-based study of triphenyl phosphate-environmental explanation of glioma progression.
Topics: Flame Retardants; Glioma; Humans; Liver Neoplasms; Male; Melatonin | 2022 |
A comprehensive analysis-based study of triphenyl phosphate-environmental explanation of glioma progression.
Topics: Flame Retardants; Glioma; Humans; Liver Neoplasms; Male; Melatonin | 2022 |
A comprehensive analysis-based study of triphenyl phosphate-environmental explanation of glioma progression.
Topics: Flame Retardants; Glioma; Humans; Liver Neoplasms; Male; Melatonin | 2022 |
The effects of melatonin on signaling pathways and molecules involved in glioma: Melatonin and glioblastoma: pathophysiology and treatment.
Topics: Glioblastoma; Glioma; Humans; Melatonin; Signal Transduction | 2020 |
5-Azacytidine upregulates melatonin MT
Topics: Animals; Azacitidine; Cell Line; Cell Line, Tumor; Epigenesis, Genetic; Gene Expression; Gene Expres | 2020 |
miR-6858 plays a key role in the process of melatonin inhibition of the malignant biological behavior of glioma.
Topics: Animals; Antioxidants; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Re | 2021 |
Melatonin inhibits proliferation and invasion via repression of miRNA-155 in glioma cells.
Topics: Antioxidants; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Glioma; Humans; Melatonin; Micr | 2017 |
The melatonin-MT1 receptor axis modulates tumor growth in PTEN-mutated gliomas.
Topics: Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Cell Proliferation; Female; Glioma; Humans; Mal | 2018 |
Mitochondria Transcription Factor A: A Putative Target for the Effect of Melatonin on U87MG Malignant Glioma Cell Line.
Topics: Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dacarbazine; DNA Replica | 2018 |
Serotoninergic and melatoninergic systems are expressed in mouse embryonic fibroblasts NIH3T3 cells.
Topics: Animals; Apolipoproteins E; Astrocytes; Brain Neoplasms; Cell Line, Tumor; Fibroblasts; Gene Express | 2013 |
Involvement of autophagy in melatonin-induced cytotoxicity in glioma-initiating cells.
Topics: Autophagy; Base Sequence; Brain Neoplasms; Flow Cytometry; Glioma; Humans; Melatonin; Microscopy, El | 2014 |
Involvement of ROS-alpha v beta 3 integrin-FAK/Pyk2 in the inhibitory effect of melatonin on U251 glioma cell migration and invasion under hypoxia.
Topics: Cell Hypoxia; Cell Line, Tumor; Cell Movement; Focal Adhesion Kinase 1; Focal Adhesion Kinase 2; Gen | 2015 |
Melatonin Protects Methamphetamine-Induced Neuroinflammation Through NF-κB and Nrf2 Pathways in Glioma Cell Line.
Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Down-Regulation; Glioma; Melatonin; Methamphetamine; NF- | 2015 |
Melatonergic system-based two-gene index is prognostic in human gliomas.
Topics: Acetylserotonin O-Methyltransferase; Animals; Brain Neoplasms; Cell Line, Tumor; Cytochrome P-450 CY | 2016 |
Melatonin suppresses methamphetamine-triggered endoplasmic reticulum stress in C6 cells glioma cell lines.
Topics: Activating Transcription Factor 6; Animals; Caspase 12; Cell Line, Tumor; Cell Survival; eIF-2 Kinas | 2017 |
Melatonin sensitizes human malignant glioma cells against TRAIL-induced cell death.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Survival; Glioma; | 2010 |
Inhibitory effects of melatonin on sulfatase and 17beta-hydroxysteroid dehydrogenase activity and expression in glioma cells.
Topics: 17-Hydroxysteroid Dehydrogenases; Animals; Antioxidants; Cell Line, Tumor; Glioma; Melatonin; Rats; | 2010 |
Melatonin suppresses migration and invasion via inhibition of oxidative stress pathway in glioma cells.
Topics: Cell Line, Tumor; Cell Movement; Cell Survival; Free Radicals; Glioma; Humans; Melatonin; NF-kappa B | 2012 |
Intracellular signaling pathways involved in the cell growth inhibition of glioma cells by melatonin.
Topics: Animals; Antioxidants; Brain Neoplasms; Cell Cycle; Cell Proliferation; Free Radicals; Glioma; Melat | 2006 |
Glioma, melatonin, and radiotherapy.
Topics: Animals; Brain Neoplasms; Glioma; Melatonin; Pineal Gland; Rats | 2006 |
Inhibitory effects of pharmacological doses of melatonin on aromatase activity and expression in rat glioma cells.
Topics: Animals; Aromatase; Down-Regulation; Enzyme Inhibitors; Estrogens; Gene Expression Regulation, Enzym | 2007 |
Involvement of protein kinase C in melatonin's oncostatic effect in C6 glioma cells.
Topics: Animals; Cell Line, Tumor; Enzyme Activation; Glioma; Melatonin; Phorbol Esters; Protein Kinase C; R | 2007 |
Glial-released proteins in clonal cultures and their modulation by hydrocortisone.
Topics: Animals; Bucladesine; Cell Line; Estradiol; Glioma; Hydrocortisone; Isoproterenol; Melatonin; Molecu | 1980 |
Induction of GDNF mRNA expression by melatonin in rat C6 glioma cells.
Topics: Animals; Antioxidants; Free Radical Scavengers; Glial Cell Line-Derived Neurotrophic Factor; Glioma; | 2002 |